| Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia W Leung, CH Pui, E Coustan-Smith, J Yang, D Pei, K Gan, A Srinivasan, ... Blood, The Journal of the American Society of Hematology 120 (2), 468-472, 2012 | 224 | 2012 |
| High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia W Leung, D Campana, J Yang, D Pei, E Coustan-Smith, K Gan, ... Blood, The Journal of the American Society of Hematology 118 (2), 223-230, 2011 | 210 | 2011 |
| Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation AB Pillai, TI George, S Dutt, P Teo, S Strober The journal of immunology 178 (10), 6242-6251, 2007 | 188 | 2007 |
| Host natural killer T cells induce an interleukin-4–dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host … AB Pillai, TI George, S Dutt, S Strober Blood, The Journal of the American Society of Hematology 113 (18), 4458-4467, 2009 | 186 | 2009 |
| NKT cells, Treg, and their interactions in bone marrow transplantation HE Kohrt, AB Pillai, R Lowsky, S Strober European journal of immunology 40 (7), 1862-1869, 2010 | 79 | 2010 |
| CyTOF® for the Masses A Iyer, AAJ Hamers, AB Pillai Frontiers in immunology 13, 815828, 2022 | 52 | 2022 |
| Interleukin 3 is a growth factor for human follicular B cell lymphoma. C Clayberger, S Luna-Fineman, JE Lee, A Pillai, M Campbell, R Levy, ... The Journal of experimental medicine 175 (2), 371-376, 1992 | 50 | 1992 |
| Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia P Rujkijyanont, C Morris, G Kang, K Gan, C Hartford, B Triplett, M Dallas, ... Blood Cancer Journal 3 (8), e137-e137, 2013 | 48 | 2013 |
| Recipient Myeloid-Derived Immunomodulatory Cells Induce PD-1 Ligand–Dependent Donor CD4+ Foxp3+ Regulatory T Cell Proliferation and Donor–Recipient Immune Tolerance After … M Van Der Merwe, HA Abdelsamed, A Seth, T Ong, P Vogel, AB Pillai The Journal of Immunology 191 (11), 5764-5776, 2013 | 31 | 2013 |
| Diagnostic clues to human herpesvirus 6 encephalitis and Wernicke encephalopathy after pediatric hematopoietic cell transplantation Z Sadighi, ND Sabin, R Hayden, E Stewart, A Pillai Journal of child neurology 30 (10), 1307-1314, 2015 | 25 | 2015 |
| Globule leukocytes and other mast cells in the mouse intestine P Vogel, L Janke, DM Gravano, M Lu, DV Sawant, D Bush, E Shuyu, ... Veterinary pathology 55 (1), 76-97, 2018 | 24 | 2018 |
| Favorable preliminary results using TLI/ATG‐based immunomodulatory conditioning for matched unrelated donor allogeneic hematopoietic stem cell transplantation in pediatric … A Pillai, C Hartford, C Wang, D Pei, J Yang, A Srinivasan, B Triplett, ... Pediatric transplantation 15 (6), 628-634, 2011 | 24 | 2011 |
| The weaned pig as a model for Doxorubicin-induced mucositis J Martin, SC Howard, A Pillai, P Vogel, AP Naren, S Davis, ... Chemotherapy 60 (1), 24-36, 2014 | 21 | 2014 |
| Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer J Datta, A Bianchi, I De Castro Silva, NU Deshpande, LL Cao, S Mehra, ... Oncogene 41 (28), 3640-3654, 2022 | 18 | 2022 |
| Expanded human regulatory iNKT cells exhibit direct cytotoxicity against hematolymphoid tumor targets W Luszczek, V Morales-Tirado, M van der Merwe, K Kudo, D Campana, ... Cancer Research 72 (8_Supplement), 3512-3512, 2012 | 17 | 2012 |
| Turning the tide for academic women in STEM: a postpandemic vision for supporting female scientists A Shah, I Lopez, B Surnar, S Sarkar, LM Duthely, A Pillai, TT Salguero, ... ACS nano 15 (12), 18647-18652, 2021 | 12 | 2021 |
| A sweet alternative: maintaining M2 macrophage polarization AAJ Hamers, AB Pillai Science immunology 3 (29), eaav7759, 2018 | 11 | 2018 |
| Successful allogeneic hematopoietic cell engraftment after a minimal conditioning regimen in children with relapsed or refractory solid tumors DR Shook, BM Triplett, A Srinivasan, C Hartford, MH Dallas, A Pillai, ... Biology of Blood and Marrow Transplantation 19 (2), 291-297, 2013 | 11 | 2013 |
| Phase I study of the safety and pharmacokinetics of plerixafor in children undergoing a second allogeneic hematopoietic stem cell transplantation for relapsed or refractory … A Srinivasan, JC Panetta, SJ Cross, A Pillai, BM Triplett, DR Shook, ... Biology of Blood and Marrow Transplantation 20 (8), 1224-1228, 2014 | 10 | 2014 |
| Effects of conditioning regimens and T cell depletion in hematopoietic cell transplantation for primary immune deficiency BM Triplett, C Wang, J Yang, M Dallas, C Hartford, V Howard, A Pillai, ... Biology of Blood and Marrow Transplantation 18 (12), 1911-1920, 2012 | 9 | 2012 |
